Drug intelligence / Profile preview

oxafuramine

Development stage
Discontinued
Lead developer
Johnson & Johnson
Modality
Small Molecules
Administration
Oral
01

Overview

Oxafuramine is a synthetic stimulant and anorectic drug belonging to the oxazoline chemical class. It is structurally related to aminorex and 4-methylaminorex. Developed in the 1960s, oxafuramine was investigated for its potential as an appetite suppressant. Its mechanism of action involves sympathomimetic activity, likely through the modulation of monoamine transporters, leading to increased levels of norepinephrine and dopamine in the synaptic cleft. Despite its pharmacological potential, oxafuramine was never approved for clinical use or widely marketed, and it remains primarily a compound of historical and toxicological interest.

Other names
2-amino-4-methyl-5-phenyl-2-oxazoline4-methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-amine
02

Targets

DAT (Dopamine plasma membrane transport protein)NET (Norepinephrine Transporter)

Beyond the preview

Go deeper on oxafuramine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oxafuramine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call